Iron deposition in the gray matter in patients with relapse-remitting multiple sclerosis: A longitudinal study using

Silin Du1, Shambhu K Sah1, Chun Zeng1

  • 1Department of Radiology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Yuzhong District, Chongqing 400016, China.

Abstract

Insights

Iron accumulation in the gray matter (GM) of patients with relapse-remitting multiple sclerosis (RRMS) increases over two years, detectable by magnetic resonance imaging (MRI). This iron concentration correlates with disease severity, offering insights into multiple sclerosis progression.

Area of Science:

  • Neuroimaging
  • Neurology
  • Biomarkers

Background:

  • Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
  • Iron accumulation in deep gray matter (GM) nuclei is implicated in neurodegeneration in MS.
  • Longitudinal assessment of iron content in MS is crucial for understanding disease progression.

Purpose of the Study:

  • To investigate the relationship between iron content in the brain's GM, measured by MRI, and clinical correlations in patients with relapse-remitting MS (RRMS) over a two-year period.
  • To assess changes in iron concentration in specific brain regions of RRMS patients compared to healthy controls.
  • To evaluate the correlation between iron levels and disease duration, disability status, and recurrence frequency.

Main Methods:

  • Thirty RRMS patients and 30 healthy controls underwent brain MRI, including conventional and 3D-enhanced T2*-weighted angiography (ESWAN) sequences, at baseline and two-year follow-up.
  • Quantitative iron content was assessed using mean phase values (MPVs) from ESWAN-filtered phase images in deep GM nuclei and the precentral gyrus.
  • Spearman's rank correlation was used to analyze relationships between MPVs and clinical parameters (disease duration, EDSS, recurrence times).

Main Results:

  • RRMS patients showed higher GM iron concentration than controls, with significant differences in substantia nigra (SN) and precentral gyrus GM (PGM).
  • Over two years, significant increases in MPVs were observed in multiple deep GM nuclei (putamen, globus pallidus, caudate nucleus, thalamus, SN, red nucleus, dentate nucleus) and PGM in RRMS patients.
  • Significant negative correlations were found between disease duration and MPVs in the caudate nucleus, dentate nucleus, and PGM, but no correlation with EDSS scores.

Conclusions:

  • Iron content in the GM is measurable using MRI and increases in RRMS patients over a two-year period compared to controls.
  • This study confirms increasing iron concentration in the GM of MS patients over time.
  • Iron concentration in the GM shows a significant correlation with disease severity, suggesting its potential as a biomarker for MS progression.